跳至主要内容
临床试验/PACTR202303867267716
PACTR202303867267716尚未招募3 期

The effectiveness of a customised digital adherence tool on HIV treatment outcomes in adolescents and young adults living with HIV in Blantyre, Malawi

Kilimanjaro Clinical Research Institute0 个研究点目标入组 240 人开始时间: 2023年3月22日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • Participants must be on first line ART regimen (Tenofovir/Lamuvidine/Dolutegravir) or (Tenofovir/Lamuvidine/Efavirenz)
  • Participants must have had full disclosure of their HIV status
  • Participants must be able to read and understand Chichewa or English
  • Participants must be competent in the use of mobile devices.

排除标准

  • Hospitalisation at the time of study entry
  • Prior participation in digital adherence health research
  • Enrolment in other HIV-related studies
  • Treatment for a comorbidity that significantly increases the participants’ pill burden.

研究者

相似试验